Data as of Sep 22
| -0.03 / -1.44%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +69.90% increase from the last price of 2.06.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.